您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2021, Vol. 59 ›› Issue (6): 51-56.doi: 10.6040/j.issn.1671-7554.0.2021.0296

• 骨质疏松症新进展专题 • 上一篇    下一篇

维生素D缺乏与2型糖尿病合并抑郁状态的相关性

刘萍1,2,宋玉文3,王萍4,田光伟1,郑凤杰3,吕丽3,杜娇娇3,张静2,庄向华3,陈诗鸿3   

  1. 1. 山东大学齐鲁医学院 山东大学第二医院, 山东 济南 250012;2. 平原县第一人民医院内分泌科, 山东 平原 253100; 3. 山东大学第二医院内分泌科, 山东 济南 250033;4. 山东大学第二医院神经内科, 山东 济南 250033
  • 发布日期:2021-06-10
  • 通讯作者: 陈诗鸿. E-mail:chenshihong26@163.com庄向华. E-mail:sd73095760653@163.com
  • 基金资助:
    国家自然科学基金(81670753,82070847,81800722);山东省重点研发计划(公益类专项)(2018GSF118108)

Correlation between vitamin D deficiency and depression in patients with type 2 diabetes mellitus

LIU Ping1,2, SONG Yuwen3, WANG Ping4, TIAN Guangwei1, ZHENG Fengjie3, LYU Li3, DU Jiaojiao3, ZHANG Jing2, ZHUANG Xianghua3, CHEN Shihong3   

  1. 1. The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, Shandong, China;
    2. Department of Endocrinology, The First Peoples Hospital of Pingyuan, Pingyuan 253100, Shandong, China;
    3. Department of Endocrinology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250033, Shandong, China;
    4. Department of Neurology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250033, Shandong, China
  • Published:2021-06-10

摘要: 目的 探讨维生素D缺乏与2型糖尿病(T2DM)合并抑郁的相关性。 方法 选取T2DM患者175例,根据抑郁自评量表(SDS)评分将患者分为抑郁组(n=74)与非抑郁组(n=101),检测血清25-羟基维生素D(25OHD)浓度,应用双能X线分析仪检测骨密度,比较两组25OHD、骨密度的差异,采用Spearman相关分析评价血清维生素D水平与SDS评分的相关性,对于单因素分析中P值较小的变量进行多因素Logistic回归分析,绘制受试者操作特征曲线(ROC)并计算曲线下面积(AUC)来评价维生素D缺乏及骨密度对于T2DM合并抑郁的诊断价值。 结果 抑郁组血清25OHD水平明显低于非抑郁组,抑郁组骨密度包括股骨颈、全髋、腰椎L1-4骨密度亦低于非抑郁组,差异有统计学意义(P<0.05);抑郁组维生素D缺乏、骨质疏松症患病率均高于非抑郁组,差异有统计学意义(P<0.05)。血清25OHD及骨密度与SDS评分呈负相关,二元Logistic回归分析结果显示维生素D缺乏(OR: 8.748,95%CI: 1.724~44.375, P=0.009)、骨质疏松症(OR: 6.385,95%CI: 2.358~17.291, P<0.001)是T2DM合并抑郁的可能影响因素。 结论 维生素D缺乏可能是T2DM合并抑郁症的危险因素,提示积极防治维生素D缺乏有助于改善T2DM患者的抑郁状态。

关键词: 维生素D, 抑郁, 骨质疏松症, 2型糖尿病

Abstract: Objective To investigate the correlation between vitamin D deficiency and depression in patients with type 2 diabetes mellitus(T2DM). Methods A total of 175 T2DM patients were selected and divided into the depression group(n=74)and non-depression group(n=101)according to the Self-Rating Depression Scale(SDS). Serum concentration of 25OHD was measured. Bone mineral density was measured with dual energy X-ray. The differences in 25OHD and BMD between the two groups were compared. The correlation between serum vitamin D level and SDS score was evaluated with Spearman correlation analysis. Multivariate Logistic regression analysis was performed for the variables with small P value in univariate analysis. The receiver operating characteristic curve(ROC)was drawn and the area under the curve(AUC)was calculated to evaluate the diagnostic value of vitamin D deficiency and bone mineral density in T2DM patients with depression. Results The serum level of 25OHD and bone mineral density of femoral neck, hip joint and lumbar 1-4 in the depression group were significantly lower than those in the non-depression group(P<0.05). The prevalence of vitamin D deficiency and osteoporosis in the depression group were higher than those in the non-depression group(P<0.05). Logistic regression analysis showed that vitamin D deficiency(OR: 8.748, 95%CI: 1.724-44.375, P=0.009)and osteoporosis(OR: 6.385, 95%CI: 2.358-17.291, P<0.001)were influencing factors of T2DM complicated with depression. Conclusion Vitamin D deficiency may be a risk factor of T2DM patients with depression. Active prevention and treatment of vitamin D deficiency may help improve the depressive state of T2DM patients.

Key words: Vitamin D, Depression, Osteoporosis, Type 2 diabetes mellitus

中图分类号: 

  • R587.2
[1] Nouwen A, Winkley K, Twisk J, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis [J]. Diabetologia, 2010, 53(12): 2480-2486.
[2] Hirani V, Cumming RG, Le Couteur DG, et al. Low levels of 25-hydroxy vitamin D and active 1, 25-dihydroxyvitamin D independently associated with type 2 diabetes mellitus in older Australian men: the concord health and ageing in men project [J]. J Am Geriatr Soc, 2014, 62(9): 1741-1747.
[3] Shen L, Zhuang QS, Ji HF. Assessment of vitamin D levels in type 1 and type 2 diabetes patients: Results from metaanalysis [J]. Mol Nutr Food Res, 2016, 60(5): 1059-1067.
[4] Grudet C, Wolkowitz OM, Mellon SH, et al. Vitamin D and inflammation in major depressive disorder [J]. J Affect Disord, 2020, 267: 33-41. doi: 10.1016/j.jad.2020.01.168.
[5] 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017)[J]. 中国骨质疏松杂志, 2019, 25(3): 281-309. Chinese Society of Osteoporosis and Bone Mineral Research. Guidelines for the diagnosis and management of primary osteoporosis(2017)[J]. Chinese Journal of Osteoporosis, 2019, 25(3): 281-309.
[6] 中华医学会骨质疏松和骨矿盐疾病分会. 维生素D及其类似物临床应用共识[J]. 中华骨质疏松和骨矿盐疾病杂志, 2018, 11(1): 1-19. Chinese Society of Osteoporosis and Bone Mineral Research. Consensus on clinical application of vitamin D and its analogues [J]. Chinese Journal of Osteoporosis and Bone Mineral Research, 2018, 11(1): 1-19.
[7] Dugan W, McDonald MV, Passik SD, et al. Use of the Zung Self-Rating Depression Scale in cancer patients: feasibility as a screening tool [J]. Psychooncology, 1998, 7(6): 483-493.
[8] 段泉泉, 胜利. 焦虑及抑郁自评量表的临床效度[J]. 中国心理卫生杂志, 2012, 26(9): 676-679. DUAN Quanquan, SHENG Li. Differential validity of SAS and SDS among psychiatric non-psychotic outpatients and their partners [J]. Chinese Mental Health Journal, 2012, 26(9): 676-679.
[9] Khaledi M, Haghighatdoost F, Feizi A, et al. The prevalence of comorbid depression in patients with type 2 diabetes: an updated systematic review and meta-analysis on huge number of observational studies [J]. Acta Diabetol, 2019, 56(6): 631-650.
[10] Lustman PJ, Griffith LS, Clouse RE. Depression in adults with diabetes. Results of 5-yr follow-up study [J]. Diabetes Care, 1988, 11(8): 605-612.
[11] Rubin RR, Ma Y, Marrero DG, et al. Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program [J]. Diabetes Care, 2008, 31(3): 420-426.
[12] de Groot M, Crick KA, Long M, et al. Lifetime duration of depressive disorders in patients with type 2 diabetes [J]. Diabetes Care, 2016, 39(12): 2174-2181.
[13] Farooqi A, Khunti K, Abner S, et al. Comorbid depression and risk of cardiac events and cardiac mortality in people with diabetes: a systematic review and meta-analysis [J]. Diabetes Res Clin Pract, 2019, 156: 107816. doi: 10.1016/j.diabres.2019.107816.
[14] Alghamdi S, Alsulami N, Khoja S, et al. Vitamin D supplementation ameliorates severity of major depressive disorder [J]. J Mol Neurosci, 2020, 70(2): 230-235.
[15] Pittas AG, Lau J, Hu FB, et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis [J]. J Clin Endocrinol Metab, 2007, 92(6): 2017-2029.
[16] Yaribeygi H, Maleki M, Sathyapalan T, et al. The molecular mechanisms by which vitamin D improve glucose homeostasis: a mechanistic review [J]. Life Sci, 2020, 244: 117305. doi: 10.1016/j.lfs.2020.117305.
[17] Herrmann M, Sullivan DR, Veillard AS, et al. Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes [J]. Diabetes Care, 2015, 38(3): 521-528.
[18] Rees G, Xie J, Fenwick EK, et al. Association between diabetes-related eye complications and symptoms of anxiety and depression [J]. JAMA Ophthalmol, 2016, 134(9): 1007-1014.
[19] Anglin RE, Samaan Z, Walter SD, et al. Vitamin D deficiency and depression in adults: systematic review and meta-analysis [J]. Br J Psychiatry, 2013, 202: 100-107. doi: 10.1192/bjp.bp.111.106666.
[20] Kalueff AV, Eremin KO, Tuohimaa P. Mechanisms of neuroprotective action of vitamin D(3)[J]. Biochemistry(Mosc), 2004, 69(7): 738-741.
[21] Berridge MJ. Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia [J]. Cell Tissue Res, 2014, 357(2): 477-492.
[22] Briggs R, McCarroll K, O Halloran A, et al. Vitamin D deficiency is associated with an increased likelihood of incident depression in community-dwelling older adults [J]. J Am Med Dir Assoc, 2019, 20(5): 517-523.
[23] Ye Z, Sharp SJ, Burgess S, et al. Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a Mendelian randomisation study [J]. Lancet Diabetes Endocrinol, 2015, 3(1): 35-42.
[24] Forouhi NG, Ye Z, Rickard AP, et al. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer(EPIC)-Norfolk cohort and updated meta-analysis of prospective studies [J]. Diabetologia, 2012, 55(8): 2173-2182.
[25] Wang Y, Yang H, Meng P, et al. Association between low serum 25-hydroxyvitamin D and depression in a large sample of Chinese patients with type 2 diabetes mellitus[J]. J Affect Disord, 2017, 224: 56-60. doi: 10.1016/j.jad.2016.10.040.
[26] Omidian M, Mahmoudi M, Abshirini M, et al. Effects of vitamin D supplementation on depressive symptoms in type 2 diabetes mellitus patients: Randomized placebo-controlled double-blind clinical trial [J]. Diabetes Metab Syndr, 2019, 13(4): 2375-2380.
[27] Kelly RR, McDonald LT, Jensen NR, et al. Impacts of psychological stress on osteoporosis: clinical implications and treatment interactions [J]. Front Psychiatry, 2019, 10: 200. doi: 10.3389/fpsyt.2019.00200.
[28] Drosselmeyer J, Rapp MA, Hadji P, et al. Depression risk in female patients with osteoporosis in primary care practices in Germany [J]. Osteoporos Int, 2016, 27(9): 2739-2744.
[29] Akpalu J, Yorke E, Ainuson-Quampah J, et al. Depression and glycaemic control among type 2 diabetes patients: a cross-sectional study in a tertiary healthcare facility in Ghana [J]. BMC Psychiatry, 2018, 18(1): 357.
[30] Mansori K, Shiravand N, Shadmani FK, et al. Association between depression with glycemic control and its complications in type 2 diabetes [J]. Diabetes Metab Syndr, 2019, 13(2): 1555-1560.
[31] Werremeyer A, Maack B, Strand MA, et al. Disease control among patients with diabetes and severe depressive symptoms [J]. J Prim Care Community Health, 2016, 7(2): 130-134.
[32] Lustman PJ, Anderson RJ, Freedland KE, et al. Depression and poor glycemic control: a meta-analytic review of the literature [J]. Diabetes Care, 2000, 23(7): 934-942.
[1] 马祎涵,袁昕赟,李嘉妮,韩旭,刁启迪,王艳,褚旭,张琨,胡蕾. 成人抑郁障碍患者童年虐待与频繁噩梦的关系:躯体症状的中介效应与社会支持的调节作用[J]. 山东大学学报 (医学版), 2026, 64(5): 96-105.
[2] 陈光辉. 跨学科协同与交叉学科聚焦的学生心理健康问题研究与干预[J]. 山东大学学报 (医学版), 2026, 64(3): 1-9.
[3] 樊呈敏,宋静雨,于书彦,毛雪琴. 舒肝解郁胶囊治疗青少年抑郁障碍的研究进展[J]. 山东大学学报 (医学版), 2026, 64(3): 17-23.
[4] 李芳华,刘娜,李晓宇,许殿花,王倩. 儿童青少年抑郁障碍患者服药依从性研究进展[J]. 山东大学学报 (医学版), 2026, 64(3): 24-34.
[5] 王倩,胡晓婧,王爱青,孙强,孟春燕,李芳华. 儿童青少年抑郁障碍患者非自杀性自伤文献的可视化分析[J]. 山东大学学报 (医学版), 2026, 64(3): 93-107.
[6] 冯雅妮,牛晓欣,麻莉娜,施叶雯,苏永龙,谢雨杉,袁钰淇,朱思敏,周雅诺,刘郝羽,刘海琴,任晓勇. 阻塞性睡眠呼吸暂停患者过度嗜睡严重程度与焦虑抑郁的相关性:一项大样本临床研究[J]. 山东大学学报 (医学版), 2026, 64(1): 19-27.
[7] 陈婵,李巨章,何稳,吴巧珍. 基于两样本孟德尔随机化研究抑郁症和抗抑郁药物靶基因与睡眠呼吸暂停的关联[J]. 山东大学学报 (医学版), 2026, 64(1): 28-36.
[8] 孟晓梅,郝亚平,王亮,于晓,唐与晓. 血清Isthmin1、Gremlin2水平与2型糖尿病患者视网膜病变的相关性[J]. 山东大学学报 (医学版), 2025, 63(9): 102-107.
[9] 申路佳,逯天威,巩伟明,赵岩松,王淑康,袁中尚. 代谢风险评分在2型糖尿病人群心血管结局预测中的应用[J]. 山东大学学报 (医学版), 2025, 63(8): 69-78.
[10] 陈莹莹,王鲁,胡锡峰,朱高培,薛付忠. 基于贝叶斯网络的2型糖尿病患者并发脑卒中风险预测[J]. 山东大学学报 (医学版), 2025, 63(8): 94-102.
[11] 刘凯林,郭莹,王志昊,耿冲,王娜娜. 基础生理指标对甲状旁腺功能的影响[J]. 山东大学学报 (医学版), 2025, 63(6): 100-106.
[12] 朱晓冉,李秀华,任延红,毛飞,方雨晴,赵张宁,王雅琳,刘天淏,张艳青,韩润冬. 帕金森病患者抑郁对睡眠、认知功能的影响[J]. 山东大学学报 (医学版), 2025, 63(3): 63-70.
[13] 王立童,王战,吴静仪,吴艳盈,李永娜,唐洪. 耳穴电针联合高频重复经颅磁刺激对卒中后抑郁的疗效[J]. 山东大学学报 (医学版), 2025, 63(11): 53-60.
[14] 孙利静,孟月茹,张召义,刘蕾,马丽瑾,房鹛. 反复种植失败患者焦虑抑郁症状与情绪调节策略的相关性研究[J]. 山东大学学报 (医学版), 2025, 63(10): 89-97.
[15] 王婷,张丽,王刚. 神经心理性哮喘[J]. 山东大学学报 (医学版), 2024, 62(5): 28-34.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!